Ligand validation:8IRE

HTG: heptyl 1-thio-beta-D-glucopyranoside

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8IRE_HTG_b_625	75%	36%	0.104	0.936	1.06	1.53	2	3	0	0	100%	1
8IRE_HTG_B_626	74%	39%	0.105	0.936	1.1	1.34	2	3	0	0	100%	1
8IRE_HTG_B_622	53%	35%	0.144	0.906	1.08	1.56	2	5	0	0	100%	1
8IRE_HTG_b_622	44%	26%	0.155	0.884	1.13	2.01	2	7	0	0	100%	1
8IRE_HTG_B_623	23%	44%	0.233	0.854	0.76	1.43	1	1	0	0	100%	1
8IRE_HTG_c_522	14%	40%	0.286	0.835	0.89	1.49	1	2	0	0	100%	1
8IRE_HTG_d_411	11%	38%	0.277	0.823	0.92	1.58	1	1	0	0	84%	0.8421
8IRE_HTG_C_522	5%	47%	0.355	0.774	0.84	1.23	1	1	0	0	100%	1
8IRE_HTG_V_203	5%	58%	0.442	0.94	0.29	1.28	-	1	0	0	58%	0.5789
8IRE_HTG_D_414	4%	36%	0.282	0.678	0.98	1.6	1	1	0	0	84%	0.8421
8IRE_HTG_b_623	2%	29%	0.493	0.759	1.01	1.97	1	3	0	0	100%	1
5V2C_HTG_O_303	94%	35%	0.072	0.972	1.58	1.07	2	2	0	0	100%	1
3WU2_HTG_O_303	89%	38%	0.092	0.971	1.17	1.32	2	1	0	0	100%	1
8IR7_HTG_b_625	81%	38%	0.086	0.939	0.97	1.5	2	3	0	0	100%	1
8IR6_HTG_b_625	81%	37%	0.088	0.941	1.07	1.48	2	4	0	0	100%	1
8IRA_HTG_B_625	81%	46%	0.097	0.95	0.97	1.12	2	2	0	0	100%	1
8IR9_HTG_B_623	81%	46%	0.098	0.95	0.99	1.13	2	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.